Definitive Contract 75F40119C10112

Award Date 9/18/19
Potential Completion Date 2/28/22
Potential Value $744K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Minneapolis, MN 55414, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
34
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) awarded a $3,000,000.00 definitive contract to the National Institute For Pharmaceutical Technology & Education Inc. (doing business as Nipte), a non-profit organization, for continuous drug substance manufacturing from biomass-derived building blocks. This contract was awarded under the FDA's Broad Agency Announcement mechanism to advance regulatory science. Nipte has previously received federal contracts and grants from the FDA to conduct research and...
This federal contract award, valued at $4,999,953.00, was granted to the National Institute For Pharmaceutical Technology & Education Inc. (Nipte), a non-profit collaboration of academia, industry, and other stakeholders that conducts research and education to advance pharmaceutical technology. The contract was awarded by the Food and Drug Administration (FDA) through its Broad Agency Announcement mechanism to support research and development on a model-based systems engineering approach...
This is a $1,259,043.67 definitive contract awarded by the Food and Drug Administration (FDA) to the National Academy of Sciences (NAS), a non-profit organization, to conduct a study on the health effects of electronic nicotine delivery systems. The contract is for research and technical advisory services, and is not set aside for any specific business type. NAS frequently receives federal contracts and grants to provide expert scientific analysis and policy advice to government agencies...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $1,874,340.00 Firm Fixed Price Definitive Contract to Njoy, LLC, a for-profit limited liability company, for the delivery of a Standardized Rechargeable Electronic Nicotine Delivery System. The contract has a period of performance from September 1, 2016 through August 31, 2017, with an ultimate completion date of May 30, 2023. The contract was not set aside for any specific business type.</p>
Technical Resources International, Inc. (TRI) has been awarded a firm fixed price purchase order valued at one million six hundred twenty four thousand one hundred twenty two dollars and twenty cents ($1,624,122.20) by the Department of Health and Human Services' Food and Drug Administration (FDA) to assess nicotine dose discrimination in marketed cigarettes. This purchase order was issued under an indefinite delivery/indefinite quantity contract held by TRI with the National Institutes of...
This is a $301,970.00 Small Business Innovation Research (SBIR) Phase I base award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to What A Smoke L.L.C. for the development and characterization of an FDA-compliant electronic vapor-based combination product. The period of performance is from September 15, 2015 to May 14, 2016, and the contract is a Firm Fixed Price Definitive Contract. There is no indication that this award is associated with a larger contract...
The Department of Health and Human Services Food and Drug Administration awarded a $1,007,954.00 definitive contract to the University of Pittsburgh - Of The Commonwealth System of Higher Education (doing business as The University of Pittsburgh) to conduct research and development on the toxicity and carcinogenicity profiling of tobacco products using organ microengineering and systems biology approaches. This contract was awarded under the FDA's Broad Agency Announcement for Advanced...
This is a Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian agency, to The Fox Foundation Inc., a non-profit organization, for $3,408,203.00. The contract is to conduct a randomized, double-blinded, within-subjects, crossover clinical laboratory study to determine whether abuse liability, as measured by nicotine exposure, subjective measures, and product use behavior, differs between e-liquids formulated with tobacco-derived nicotine (TDN) and non-tobacco...
This federal contract award from the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization, is for investigating the effects of nicotine pouch flavors on abuse liability in smokeless tobacco users. The $1,923,145.00 firm fixed-price delivery order has a period of performance ending on May 30, 2026. The award does not have a set-aside designation. Battelle has subcontracted with Montrose Environmental Group, Inc., an environmental...
The U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $1,373,557.00 firm fixed price purchase order contract to Research Triangle Institute (RTI) International, a non-profit research organization, to investigate the effects of waterpipe physical design parameters on harmful and potentially harmful constituent (HPHC) yields in smoke and charcoal emissions. The contract, which does not have a set-aside designation, has a completion date of May 14,...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $743,717.94 Definitive Contract to the National Institute For Pharmaceutical Technology & Education Inc. (Nipte), a non-profit organization, to conduct research and development on the assessment of smoking and vaping risk of opioids and commercial products, as well as the standardization of methods to assess these properties. This contract was issued under the FDA's Broad Agency Announcement mechanism to advance regulatory science. Nipte has previously received other FDA contracts to support the agency's work on continuous drug manufacturing and model-based pharmaceutical production systems.

Generated 3/24/24, 2:08 AM